Marina Padroni

Neurosarcoidosis-like reaction under TNF-α inhibitors: a case report and literature review of a paradoxical immune phenomenon

The role of computed tomography in thrombus characterization: Insights from a stroke cohort of known and unknown etiology

Timing of anticoagulation therapy in patients with acute ischemic stroke and atrial fibrillation: a GRADE-based expert opinion recommendation

ABSTRACT NUMBER: ESOC2026A2195 TIMING OF ANTICOAGULATION THERAPY IN PATIENTS WITH ACUTE ISCHEMIC STROKE AND ATRIAL FIBRILLATION: A GRADE-BASED EXPERT OPINION RECOMMENDATION

A case of sporadic hemiplegic migraine treated with eptinezumab: should we consider anti-CGRP antibodies for selected patients?

Long-Term Risk of Recurrent Cervical Artery Dissection and Stroke After Pregnancy

Intravenous thrombolysis in patients with acute ischaemic stroke and active cancer (the ITACA-stroke study)

Risk Profile of Patients with Spontaneous Cervical Artery Dissection

Cerebral Venous Thrombosis during Thyrotoxicosis: Case Report and Literature Update

Reversible cerebral vasoconstriction syndrome: strategies to early diagnosis and the role of transcranial color-coded doppler ultrasonography (TCCD)

Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study

An atypical Takotsubo cardiomyopathy in a typical myasthenic crisis

Stroke admissions during the COVID-19 pandemic: a single-center retrospective analysis

Case Report: A Case of Creutzfeldt–Jakob Heidenhain Variant Simulating PRES

Endovascular Thrombectomy for Acute Ischemic Stroke Beyond 6 Hours From Onset

Combined intravenous and endovascular treatment versus primary mechanical thrombectomy. The Italian Registry of Endovascular Treatment in Acute Stroke

Bilateral Hypoglossal Nerve Palsy in an Adult Patient With Repaired Tetralogy of Fallot

Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up

Cerebral Blood Volume ASPECTS Is the Best Predictor of Clinical Outcome in Acute Ischemic Stroke: A Retrospective, Combined Semi-Quantitative and Quantitative Assessment

Anti‐ApoA‐1 IgG serum levels predict worse poststroke outcomes

Decreased serum <scp>PCSK</scp>9 levels after ischaemic stroke predict worse outcomes

CBV_ASPECTS Improvement over CT_ASPECTS on Determining Irreversible Ischemic Lesion Decreases over Time

Serum levels of anti-apolipoprotein A-1 IGG are associated with long-term disability and cerebral lesion volume in acute ischemic stroke patients

Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke

Leptin/adiponectin ratio predicts poststroke neurological outcome

CT perfusion cerebral blood volume does not always predict infarct core in acute ischemic stroke

Comparison of Antibodies Hydrolyzing Myelin Basic Protein from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis

Comparison of DNA-Hydrolyzing Antibodies from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis